While everyone agrees that the announced tariffs are negative at least in the near-term, the range of potential outcomes is very wide and impossible to define precisely. Not only are the indirect ...

IBS-C with constipation affects millions of Americans. Learn about symptoms, causes, and treatment options that can help ...

Minnesota’s early season performance has been a mixed bag, leaving fans scratching their heads and analysts mulling over what to expect as the season unfolds. At the same time, there are some reasons ...

The worst thing Activision can do is listen to people who want to make Verdansk play like Rebirth Island.

Significant losses in leading IT stocks such as Tata Consultancy Services (TCS), Infosys, Wipro, HCL Technologies, and ...

Track real-time economic trends with this week's high-frequency indicators. Read more on leading signals on consumer spending ...

To effectively mine real estate data, professionals should start by identifying key data sources relevant to their operations. For example, public records, MLS listings, and property tax assessments ...

The FDA approved Amgen's Uplizna as the first treatment for IgG4-RD. The decision is backed by the MITIGATE trial, showing reduced flares and sustained efficacy.

Amgen (NASDAQ:AMGN) announced today that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA as the first and onl ...

Sanofi's rilzabrutinib receives FDA orphan drug designation for two rare diseases. Clinical studies show meaningful response ...

Dun & Bradstreet and SIDBI release the SPeX, or 'Green Pulse Indicator', assessing MSME's sustainability perception across willingness, awareness, and implementation. Despite a 5.3% decline in Q4 2024 ...

Chart review has mostly been a manual process, has been prone to error, and is an area where extracting actionable insights ...